Sun Pharmaceutical Ltd.

Sun Pharmaceutical Industries Limited (Sun Pharma) is an Indian multinational pharmaceutical

company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and
active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. Sun
Pharmaceuticals was founded by Dilip Shanghvi in 1983[8] in Vapi, Gujarat. The 2014 acquisition of
Ranbaxy made Sun Pharma the largest pharma company in India, the largest Indian pharma company in
the US, and the 4th largest specialty generic company globally. Over 72% of Sun Pharma sales are from
markets outside India, primarily in the United States. The US is the single largest market, accounting for
about 30% of the company's turnover in all, formulations or finished dosage forms, account for
93% of the turnover. Sun Pharma was listed on the stock exchange in 1994 in an issue
oversubscribed 55 times. The founding family continues to hold a majority stake in the
company.

Capital Structure: -

Ratios: -
Ratios MAR 23 MAR 22 MAR 21 MAR 20 MAR 19
Debt Equity 0.32 0.20 0.26 0.24 0.26
Dividend / 11.50 10.00 7.50 4.00 2.75
Share (Rs.)
Dividend Payout 22.89 39.85 31.28 23.70 10.84
Ratio(%)
 Current Ratio 2.00 2.04 1.89 2.02 1.79
Return on Net 15.13 6.81 6.24 8.31 6.43
worth/Equity(%
)
Quick Ratio 1.48 1.51 1.33 1.51 1.34

Share Price: -
The share price of any stocks is volatile and keeps changing throughout the day owing
to different factors. Sun Pharmaceutical share price is ₹1,131.90 as of 6 Sep '23.

Returns: -
For the year ending March 2023 Sun Pharmaceutical Industries has declared an equity
dividend of 1150.00% amounting to Rs 11.5 per share. At the current share price of Rs 1109.00
this results in a dividend yield of 1.04%.